Please login to the form below

Not currently logged in
Email:
Password:

BIA says action plan could quadruple R&D output by 2025

Claims it could rank the UK in the global top three largest biotech clusters

Mylan pulls no punches in rejecting Teva takeover

MylanFirm calls Israeli generics giant’s credibility into question

Sanofi gains accelerated review for rare disease drug

Sanofi receptionNew pill for Fabry disease could be approved by the FDA before the end of the year

Celgene to acquire biotech firm Quanticel Pharmaceuticals

Celgene buildingFirm hopes to expand its pipeline of life-enhancing products for cancer patients

Payment to docs rules ‘an opportunity for pharma’

The industry’s reputation can be boosted by openness, say pharma compliance leaders

INC Research and DrugDev collaborate to push clinical trials

Aims to create cloud-based solutions to boost efficacy

BMS' Opdivo backed as melanoma therapy in EU

Bristol-Myers Squibb (BMS) buildingFirst checkpoint inhibitor to be recommended for approval in the region

Health wins big at second UK Blog Awards

Evidently Cochrane named Company Health Blog of the Year

Teva circling as Perrigo rejects second Mylan offer

MylanClaims latest offer is lower than a recent informal bid

Is a UK market access shake-up on the cards?

Former coalition government health minister Paul Burstow tells PMLiVE that NICE, QALY and broader issues of market access in England are all being put under review

Latest appointments

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Biosector 2

Biosector 2 (B2) is a global healthcare public relations agency that partners with visionary clients to deliver groundbreaking programs and...

Latest intelligence

MORE MONEY FOR THE NHS – BUT IS THIS THE ANSWER?
Paul Mannu of Cello Health Insight says that politicians opening their pre-election cheque books can’t put the NHS where it needs to be – but pharma can play a major...
Medius Deal Watch
Pharma deals in February 2015
Pfizer and Valeant led the way during a respectable, if not record-breaking, month for mergers, acquisitions and collaborations...
Medius Deal Watch
Medius Deal Watch table for February 2015
The top major pharma mergers, acquisitions and collaborations during the month were led by the Pfizer/Hospira and Salix/Valeant deals...

Infographics